Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates
Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates 4

Getting a diagnosis of advanced bladder cancer can feel scary. But knowing what you’re dealing with is the first step to making good choices about your health. We’re here to help you understand Stage 3 bladder cancer. This is when the cancer has grown through the muscle layer into fatty tissue around it. It might also have spread to nearby lymph nodes. Learn about stage 3 bladder cancer symptoms, treatment, prognosis, and survival rates. A complete overview of advanced bladder cancer.

The five-year survival rate for this stage is about 39 percent, based on recent data. Spotting symptoms like blood in the urine early and seeing a doctor quickly can really help. We’ll look at what Stage 3 bladder cancer is, its outlook, and treatment choices to guide you.

Key Takeaways

  • Stage 3 bladder cancer is characterized by the cancer spreading to surrounding fatty tissue and possibly nearby lymph nodes.
  • The five-year relative survival rate is approximately 39 percent.
  • Early symptom recognition and medical consultation are critical.
  • Understanding the prognosis and treatment options is vital for informed decision-making.
  • Patients have multiple pathways to explore with their healthcare team.

Understanding Stage 3 Bladder Cancer

Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates
Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates 5

Stage 3 bladder cancer is a serious condition. It means the cancer has grown through the bladder’s muscle layer and into the fat layer around it. It might also have spread to nearby organs or lymph nodes, making it more advanced.

Definition and Classification of Muscle-Invasive Bladder Cancer

Stage 3 bladder cancer is known as muscle-invasive bladder cancer. This means it has gone through the bladder’s muscle wall. It’s a more serious type of cancer that needs stronger treatments.

How Stage 3 Differs from Other Stages

Stage 3 bladder cancer is different from earlier stages. Stages 1 and 2 are not as deep in the bladder. Stage 3 has grown beyond the bladder, possibly reaching nearby organs or lymph nodes. This makes it stand out from other stages.

Knowing the difference between stage 3 and other stages is key. It helps doctors choose the right treatment and understand what to expect. We’ll look into this more in the next sections.

Stage 3 Bladder Cancer Symptoms

Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates
Stage 3 Bladder Cancer Symptoms: Prognosis & Survival Rates 6

Knowing the symptoms of stage 3 bladder cancer is key for early treatment. We’ll look at both early signs and advanced symptoms as the cancer grows.

Early Warning Signs and Hematuria

Hematuria, or blood in the urine, is a common early sign. It makes urine look pink, red, or dark brown. This symptom is often painless, making it hard to notice.

Other early signs include:

  • Frequent urination
  • Urgency to urinate
  • Painful urination
  • Nocturia (getting up at night to urinate)

These symptoms can be like those of less serious issues. It’s important to see a doctor for a correct diagnosis.

Advanced Symptoms as Cancer Progresses

As stage 3 bladder cancer gets worse, more symptoms appear. These can really affect your life. They include:

  • Lower back pain on one side
  • Difficulty urinating or complete inability to urinate
  • Swelling in the lower legs and feet due to possible spread to nearby tissues

Telling your healthcare team about new or getting worse symptoms is key. They can change your treatment plan.

Handling these symptoms is tough. Our healthcare team is here to offer full support and care. We aim to manage these symptoms well.

How Stage 3 Bladder Cancer Affects the Body

Stage 3 bladder cancer is a serious point where the cancer’s impact grows. It affects many health areas. At this stage, the cancer has grown through the bladder’s muscle layer. It may also spread to nearby tissues or lymph nodes.

Spread to Surrounding Fatty Tissue

Stage 3 bladder cancer often spreads to fatty tissue around it. This tissue, or adipose tissue, helps the cancer spread further. As it invades this tissue, it can cause pain and discomfort in the pelvic area.

Gender-Specific Impacts

Stage 3 bladder cancer affects men and women differently. In men, it can reach the prostate. In women, it may affect the uterus or other nearby structures. Knowing these differences is key for effective treatment plans.

Potential Lymph Node Involvement

Lymph nodes are a big concern in stage 3 bladder cancer. When cancer cells get to the lymph nodes, it means the disease is more advanced. Lymph nodes filter out harmful substances, including cancer cells.

If cancer reaches the lymph nodes, treatment plans may change. Checking for lymph node involvement is important. It helps accurately stage the cancer and plan the right treatment.

Diagnosis and Staging Process

To find out if someone has Stage 3 bladder cancer, doctors use many tests. These tests help figure out how far the cancer has spread. They also help decide the best treatment.

Diagnostic Tests and Procedures

There are several tests to find bladder cancer. Cystoscopy uses a thin tube with a camera to see inside the bladder. The Transurethral Resection of Bladder Tumor (TURBT) removes a tumor or a sample for checking.

CT scans, MRI, and ultrasound are used too. They help see if the cancer has spread to nearby tissues or lymph nodes. This info is key for planning treatment.

Confirming Stage 3 Classification

Doctors use tests to see if the cancer is Stage 3. They check if the cancer has gone into the bladder’s muscle layer. They also look if it has spread to fatty tissue or lymph nodes.

The stage of cancer is very important. It helps decide how to treat Stage 3 bladder cancer. Treatments might include surgery, chemotherapy, or radiation therapy.

Diagnostic TestPurpose
CystoscopyVisual examination of the bladder interior
TURBTRemoval of tumor for biopsy
CT ScanAssess cancer spread to surrounding tissues and lymph nodes
MRIDetailed imaging of soft tissues
UltrasoundEvaluation of bladder and surrounding structures

Getting the cancer stage right is very important. It helps know what to expect and how to treat it. We help patients understand their diagnosis and treatment plan.

Treatment Options for Stage 3 Bladder Cancer

Patients with Stage 3 bladder cancer have several treatment options. These choices depend on their health and what they prefer. Usually, a mix of treatments is used to get the best results.

Surgical Approaches

Surgery is a key treatment for Stage 3 bladder cancer. The main surgery is a radical cystectomy. This means removing the bladder, nearby lymph nodes, and sometimes other organs.

For men, this might include taking out the prostate and seminal vesicles. Women might have their uterus, ovaries, and part of the vagina removed.

After surgery, there are different ways to handle urine. These include:

  • Ileal conduit: A piece of intestine used to divert urine.
  • Neobladder: A new bladder made from intestine for natural urination.
  • Continent urinary reservoir: A pouch for urine, drained by catheter.

Chemotherapy Protocols and Success Rates

Chemotherapy is often used with surgery or radiation. Neoadjuvant chemotherapy is given before surgery to shrink the tumor. Adjuvant chemotherapy is after surgery to kill any remaining cancer cells.

The success of chemotherapy varies. But studies show it can improve survival rates for muscle-invasive bladder cancer.

Chemotherapy ProtocolSuccess Rate
Neoadjuvant ChemotherapyImproved survival rates by up to 15%
Adjuvant ChemotherapyReduces risk of recurrence by up to 20%

Radiation Therapy and Combination Treatments

Radiation therapy is another option for Stage 3 bladder cancer. It’s often used with chemotherapy. External beam radiation therapy (EBRT) uses beams from outside the body to target cancer cells.

Combining chemotherapy and radiation can be effective. It might help keep the bladder. The choice depends on the patient’s health, cancer stage, and personal preferences.

Stage 3 Bladder Cancer Survival Rates

Stage 3 bladder cancer survival rates give us insights into what to expect. They are key for patients and their families facing cancer treatment.

Five-Year Relative Survival Statistics

The five-year survival rate for stage 3 bladder cancer is about 39.5 percent. This means patients with stage 3 cancer have a 39.5% chance of living at least five years after diagnosis. Survival rates depend on many things, like the cancer’s stage, overall health, and how well treatment works.

Getting a stage 3 bladder cancer diagnosis can feel scary. But knowing the survival rates helps in talking about treatment plans with doctors.

Factors Affecting Survival Outcomes

Many things can change how long someone with stage 3 bladder cancer might live. These include:

  • The cancer’s stage and type
  • The patient’s overall health and any other health issues
  • How well the chosen treatment works
  • How the patient responds to treatment

Doctors can give more tailored advice and support by thinking about these factors. This helps patients on their treatment path.

In summary, while the five-year survival rate for stage 3 bladder cancer is important, it’s just one part of understanding the disease. We suggest patients talk to their healthcare team about their specific situation and treatment options. This way, they can get a better idea of what to expect.

Prognosis and Life Expectancy

The outlook for stage 3 bladder cancer depends on several things. These include the cancer’s details and the patient’s health. Knowing these factors helps patients understand their life expectancy and treatment results.

Determinants of Prognosis

Several key factors affect the prognosis for stage 3 bladder cancer. These include:

  • The extent of the tumor and whether it has invaded the muscle layer of the bladder
  • Lymph node involvement, which indicates the cancer has begun to spread
  • The patient’s overall health, including the presence of other medical conditions
  • The effectiveness of the chosen treatment protocol

Lymph node involvement is a critical factor, as it signifies that the cancer is progressing beyond the initial site. The number and location of affected lymph nodes can significantly influence the prognosis.

Possibilities for Remission and Long-term Outlook

Patients with stage 3 bladder cancer have a chance of achieving remission and long-term survival. The likelihood of remission depends on factors like tumor characteristics and lymph node involvement.

With the right treatment, some patients can achieve complete remission. This means there’s no cancer evidence after treatment. The five-year relative survival rate for stage 3 bladder cancer gives insight into the long-term outlook. Yet, individual results can vary a lot.

We stress that each patient’s journey is unique. While statistics offer a general view, they don’t predict individual outcomes. Factors like treatment response and overall health greatly influence long-term survival.

Living with Stage 3 Bladder Cancer

Living with stage 3 bladder cancer needs a full plan. This includes handling treatment side effects and getting emotional support. We know this diagnosis is tough, but with the right help, patients can get through it.

Managing Treatment Side Effects

It’s key to manage side effects well to keep quality of life. Side effects like fatigue, urinary issues, and bowel changes are common. Patients should work with their healthcare team to find ways to lessen these effects.

Strategies for managing side effects might include changing diets, taking meds, or trying acupuncture or meditation. Keeping a symptom journal helps track side effects and talk to doctors about them.

Follow-up Care and Monitoring

Follow-up care is vital for stage 3 bladder cancer patients. Regular visits help catch any signs of the cancer coming back early. Patients should stick to their follow-up schedule and tell their doctors about any new symptoms.

How often to visit the doctor depends on the treatment and health. Follow-up care often includes tests, blood work, and physical checks. Being active and alert about follow-up care is important for long-term success.

Emotional and Psychological Support Resources

Emotional and psychological support is key for stage 3 bladder cancer patients. The emotional impact of the disease can be as tough as the physical. Support groups, counseling, and online resources can offer comfort and advice.

Patients should look into different support options to find what suits them best. Whether it’s talking to others who’ve gone through similar things or getting professional help, there are many resources to help with the emotional side of living with stage 3 bladder cancer.

Conclusion

Understanding stage 3 bladder cancer is key for patients to handle their diagnosis and treatment well. We’ve looked at the signs, diagnosis, and treatment options for this condition. It’s important to have a full care plan and support.

The survival rate for bladder cancer changes based on treatment success. Knowing this helps patients set realistic goals and make smart care choices.

Dealing with stage 3 bladder cancer needs a mix of treatments like surgery, chemo, and radiation. A treatment plan made just for you can help improve your chances of survival and quality of life.

In conclusion, managing stage 3 bladder cancer needs a whole approach. This includes medical care, emotional support, and ongoing check-ups. With the help of healthcare experts, patients can face this tough time with hope and confidence.

FAQ

What is stage 3 bladder cancer?

Stage 3 bladder cancer is a serious form of bladder cancer. It grows into the muscle layer of the bladder. It might also spread to nearby organs or lymph nodes.

What are the symptoms of stage 3 bladder cancer?

Symptoms include blood in the urine, needing to urinate often, and pain while urinating. You might also feel pain in your abdomen.

How is stage 3 bladder cancer diagnosed?

Doctors use tests like cystoscopy and CT scans to find the cancer. A biopsy confirms the cancer’s stage and how far it has spread.

What are the treatment options for stage 3 bladder cancer?

Treatments include surgery, chemotherapy, and radiation. The best option depends on the cancer and your health.

What is the survival rate for stage 3 bladder cancer?

The five-year survival rate is about 40-50%. This is for cases where the cancer has spread to nearby areas.

Can stage 3 bladder cancer be cured?

While “cure” is complex, some people can go into remission. This can greatly improve their life expectancy.

What factors affect the prognosis of stage 3 bladder cancer?

Your prognosis depends on how far the cancer has spread. It also depends on your health, how well you respond to treatment, and if it has invaded nearby areas.

How does stage 3 bladder cancer impact quality of life?

It can greatly affect your life, causing problems with urination and emotional health. It also impacts your physical health.

What support resources are available for patients with stage 3 bladder cancer?

There are many resources like support groups and counseling. Healthcare teams also specialize in bladder cancer care.

What is the life expectancy after being diagnosed with stage 3 bladder cancer?

Life expectancy varies. It depends on how well treatment works, your health, and any other health conditions you have.

How does chemotherapy success rate vary for stage 3 bladder cancer?

Success rates vary. They depend on how well the cancer responds to treatment, your health, and if you’re getting chemotherapy alone or with other treatments.

What are the advanced symptoms of bladder cancer?

Advanced symptoms include severe pain and significant weight loss. Signs of cancer spreading to other parts of the body also indicate a worse disease progression.

References

  1. Government Health Resource. (2025). Stage 3 Bladder Cancer Symptoms Prognosis  Survival. Retrieved from https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/survival-rates.html
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75